Kalos Management’s Acadia Pharmaceuticals ACAD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q3 | – | Sell |
-17,075
| Closed | -$244K | – | 44 |
|
|
2022
Q2 | $244K | Sell |
17,075
-1,150
| -6% | -$16.4K | 0.33% | 102 |
|
|
2022
Q1 | $441K | Sell |
18,225
-1,464
| -7% | -$35.4K | 0.3% | 75 |
|
|
2021
Q4 | $340K | Buy |
19,689
+1,114
| +6% | +$19.2K | 0.09% | 207 |
|
|
2021
Q3 | $321K | Sell |
18,575
-100
| -0.5% | -$1.73K | 0.09% | 210 |
|
|
2021
Q2 | $433K | Hold |
18,675
| – | – | 0.18% | 149 |
|
|
2021
Q1 | $460K | Sell |
18,675
-275
| -1% | -$6.77K | 0.14% | 164 |
|
|
2020
Q4 | $1.01M | Sell |
18,950
-500
| -3% | -$26.7K | 0.43% | 74 |
|
|
2020
Q3 | $812K | Buy |
19,450
+100
| +0.5% | +$4.18K | 0.36% | 84 |
|
|
2020
Q2 | $935K | Buy |
19,350
+3,600
| +23% | +$174K | 0.39% | 83 |
|
|
2020
Q1 | $672K | Sell |
15,750
-3,000
| -16% | -$128K | 0.3% | 93 |
|
|
2019
Q4 | $795K | Hold |
18,750
| – | – | 0.29% | 101 |
|
|
2019
Q3 | $680K | Hold |
18,750
| – | – | 0.27% | 105 |
|
|
2019
Q2 | $501K | Buy |
18,750
+4,829
| +35% | +$129K | 0.23% | 111 |
|
|
2019
Q1 | $373K | Sell |
13,921
-6,129
| -31% | -$164K | 0.24% | 99 |
|
|
2018
Q4 | $420K | Buy |
20,050
+800
| +4% | +$16.8K | 0.2% | 113 |
|
|
2018
Q3 | $392K | Buy |
19,250
+1,400
| +8% | +$28.5K | 0.21% | 110 |
|
|
2018
Q2 | $416K | Hold |
17,850
| – | – | 0.19% | 132 |
|
|
2018
Q1 | $416K | Sell |
17,850
-800
| -4% | -$18.6K | 0.25% | 94 |
|
|
2017
Q4 | $558K | Buy |
18,650
+3,500
| +23% | +$105K | 0.26% | 106 |
|
|
2017
Q3 | $570K | Buy |
+15,150
| New | +$570K | 0.37% | 83 |
|
|
2017
Q2 | – | Sell |
-10,600
| Closed | -$364K | – | 102 |
|
|
2017
Q1 | $364K | Hold |
10,600
| – | – | 0.26% | 100 |
|
|
2016
Q4 | $306K | Buy |
10,600
+1,750
| +20% | +$50.5K | 0.25% | 100 |
|
|
2016
Q3 | $282K | Buy |
8,850
+1,750
| +25% | +$55.8K | 0.24% | 117 |
|
|
2016
Q2 | $230K | Buy |
+7,100
| New | +$230K | 0.18% | 134 |
|